Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate.
Am. J. Obstet. Gynecol., Aug;205(2):135.e1-9 (2011)
Influence of maternal body mass index and gestational age on accuracy of first trimester gender assignment.
J. Matern. Fetal. Neonatal. Med., Mar;25(3):253-6 (2012)
Glycemic characteristics and neonatal outcomes of women treated for mild gestational diabetes.
Obstet Gynecol., Apr;117(4):819-27 (2011)
Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.
Curr. Diab. Rep., Feb;11(1):28-34 (2011)
Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-Î± hydroxyprogesterone caproate.
J. Matern. Fetal. Neonatal. Med., Dec;23(12):1360-4 (2010)
The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time.
Am. J. Obstet. Gynecol., Oct;201(4):410.e1-5 (2009)
A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
J. Matern. Fetal. Neonatal. Med., May;21(5):309-13 (2008)
Myometrial thickness according to uterine site, gestational age and prior cesarean delivery.
J. Matern. Fetal. Neonatal. Med., Apr;21(4):247-50 (2008)
The Maternal-Fetal Medicine Units Cesarean Registry: safety and efficacy of a trial of labor in preterm pregnancy after a prior cesarean delivery.
Am. J. Obstet. Gynecol., Oct;195(4):1119-26 (2006)
Rates of recurrent preterm birth by obstetrical history and cervical length.
Am. J. Obstet. Gynecol., Sep;193(3 Pt 2):1170-4 (2005)
The influence of obesity and diabetes on the risk of cesarean delivery.
Am. J. Obstet. Gynecol., Sep;191(3):969-74 (2004)
The impact of maternal obesity and weight gain on vaginal birth after cesarean section success.
Am. J. Obstet. Gynecol., Sep;191(3):954-7 (2004)